Catalyst Funds Management Pty LTD Mannkind Corp Transaction History
Catalyst Funds Management Pty LTD
- $662 Billion
- Q3 2025
A detailed history of Catalyst Funds Management Pty LTD transactions in Mannkind Corp stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 27,235 shares of MNKD stock, worth $137,809. This represents 0.02% of its overall portfolio holdings.
Number of Shares
27,235
Previous 81,100
66.42%
Holding current value
$137,809
Previous $408 Million
64.15%
% of portfolio
0.02%
Previous 0.11%
Shares
4 transactions
Others Institutions Holding MNKD
# of Institutions
257Shares Held
165MCall Options Held
2.76MPut Options Held
689K-
Black Rock Inc. New York, NY22.6MShares$114 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$89.2 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY11.4MShares$57.8 Million1.01% of portfolio
-
State Street Corp Boston, MA10.7MShares$54.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA7.39MShares$37.4 Million0.0% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.3B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...